ClassID:

95301

C07D417/12 - page 9 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#2401
20170014381
2017-01-19

Somatostatin receptor subtype 4 (SSTR4) agonists

#2402
20170008904
2017-01-12

MDM2-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE

#2403
20170008884
2017-01-12

Cysteine protease inhibitors and uses thereof

#2404
20170008878
2017-01-12

Heterocyclic amides as kinase inhibitors

#2405
20170008847
2017-01-12

Alkynyl pyridine-substituted amide compound and pesticide

#2406
20170008844
2017-01-12

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#2407
20170001998
2017-01-05

Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists

#2408
20170001994
2017-01-05

Cyclopropanamine compound and use thereof

#2409
20170001993
2017-01-05

Compounds, compositions, and methods for increasing CFTR activity

#2410
20170001991
2017-01-05

Compounds, compositions, and methods for increasing CFTR activity

#2411
20170001984
2017-01-05

Cycloalkane derivatives

#2412
20170001955
2017-01-05

4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

#2413
20160376266
2016-12-29

Anti-alphavbeta1 integrin compounds and methods

#2414
20160376238
2016-12-29

Therapeutic compounds

#2415
20160376237
2016-12-29

NOVEL PYRIDINE DERIVATIVES

#2416
20160368930
2016-12-22

Compositions and methods for treating cancer

#2417
20160368918
2016-12-22

Syk inhibitors

#2418
20160368907
2016-12-22

PRMT5 inhibitors and uses thereof

#2419
20160368906
2016-12-22

Bicyclic heterocyclic derivatives as bromodomain inhibitors

#2420
20160368904
2016-12-22

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

#2421
20160368903
2016-12-22

Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders

#2422
20160368883
2016-12-22

Isoxazoline derivatives as insecticides

#2423
20160368881
2016-12-22

Therapeutic compounds

#2424
20160368874
2016-12-22

1,4-substituted piperidine derivatives

#2425
20160367563
2016-12-22

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use

#2426
20160367531
2016-12-22

Antimicrobial agents

#2427
20160366887
2016-12-22

Azoline compounds

#2428
20160362439
2016-12-15

Cyclic peroxides as prodrugs for selective delivery of agents

#2429
20160362421
2016-12-15

Fused heterocyclic compounds as ion channel modulators

#2430
20160362398
2016-12-15

Amide compounds for treatment of complement mediated disorders

#2431
20160362396
2016-12-15

Quinazolines as potassium ion channel inhibitors

#2432
20160362393
2016-12-15

ENDOPARASITE CONTROL AGENT

#2433
20160361329
2016-12-15

COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#2434
20160361287
2016-12-15

Compositions and methods for inhibiting cytochrome P450

#2435
20160355499
2016-12-08

TRPV1 antagonists including dihydroxy substituent and uses thereof

#2436
20160354374
2016-12-08

Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith

#2437
20160354355
2016-12-08

Deuterium-enriched pioglitazone

#2438
20160347768
2016-12-01

Compounds for use as GPR120 agonists

#2439
20160347767
2016-12-01

Heterocycle amines and uses thereof

#2440
20160347760
2016-12-01

Bicyclic-fused heteroaryl or aryl compounds

#2441
20160347748
2016-12-01

Benzamide and nicotinamide compounds and methods of using same

#2442
20160340386
2016-11-24

Cytotoxic tubulysin compounds for conjugation

#2443
20160340351
2016-11-24

Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors

#2444
20160340350
2016-11-24

Separation method for active pharmaceutical ingredients (apis) from excipients in pharmaceutical formulations

#2445
20160340341
2016-11-24

Substituted benzooxadiazole DNA-PK inhibitors

#2446
20160340326
2016-11-24

Tizoxanide carbamate and pharmaceutical use thereof

#2447
20160340315
2016-11-24

Factor XIa inhibitors

#2448
20160339114
2016-11-24

Tubulysin derivatives

#2449
20160339000
2016-11-24

Triazolone compounds as mPGES-1 inhibitors

#2450
20160338996
2016-11-24

2-acylaminopropoanol-type glucosylceramide synthase inhibitors

#2451
20160333004
2016-11-17

Substituted bicyclic heteroaryl compounds as RXR agonists

#2452
20160333000
2016-11-17

Pyrimidinyloxy benzene derivatives as herbicides

#2453
20160332975
2016-11-17

ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS

#2454
20160332970
2016-11-17

Histone demethylase inhibitors

#2455
20160332966
2016-11-17

Indole compound

#2456
20160331749
2016-11-17

Bromodomain inhibitors

#2457
20160331737
2016-11-17

Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone

#2458
20160331013
2016-11-17

Sweet flavor modifier

#2459
20160326195
2016-11-10

Tricyclic sulfones as RORγ modulators

#2460
20160326174
2016-11-10

Modulators of and methods of making and using thereof

#2461
20160326170
2016-11-10

Substituted 6,5-fused bicyclic heteroaryl compounds

#2462
20160326158
2016-11-10

Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity

#2463
20160326157
2016-11-10

MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE

#2464
20160326156
2016-11-10

Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors

#2465
20160326155
2016-11-10

C-6 spirocarbocyclic iminothiadiazine dioxides as BACE inhibitors, compositions, and their use

#2466
20160326154
2016-11-10

BICARBOCYCLIC AND TRICARBOCYCLIC ETHYNYL DERIVATIVES AND USES OF SAME

#2467
20160326146
2016-11-10

Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase

#2468
20160326125
2016-11-10

Sulfone amide linked benzothiazole inhibitors of endothelial lipase

#2469
20160324828
2016-11-10

Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases

#2470
20160324155
2016-11-10

Thiazole compound and its use in pest control

#2471
20160318920
2016-11-03

TRPV1 antagonists including dihydroxy substituent and uses thereof

#2472
20160318919
2016-11-03

Oxime-substituted amide compound and pest control agent

#2473
20160318918
2016-11-03

Small molecule modifiers of the Hec1-Nek2 interaction in G2/M

#2474
20160318886
2016-11-03

Compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor

#2475
20160318871
2016-11-03

Inhibitor compounds of phosphodiesterase type 10A

#2476
20160318870
2016-11-03

RORγ modulators

#2477
20160318869
2016-11-03

Heterocyclic compounds for the treatment of neurological and psychological disorders

#2478
20160318864
2016-11-03

4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors

#2479
20160318852
2016-11-03

Benzamides and nicotinamides as Syk modulators

#2480
20160317532
2016-11-03

Compounds useful as modulators of TRPM8

#2481
20160311833
2016-10-27

Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments

#2482
20160311818
2016-10-27

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

#2483
20160311814
2016-10-27

Cyclopropanamine compound and use thereof

#2484
20160311813
2016-10-27

Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors

#2485
20160311812
2016-10-27

ADENOSINE A1 AGONISTS AS MEDICAMENTS FOR KIDNEY DISORDERS

#2486
20160311808
2016-10-27

Cyclopropanamine compound and use thereof

#2487
20160311802
2016-10-27

Biaryl inhibitors of Bruton's tyrosine kinase

#2488
20160311787
2016-10-27

Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease

#2489
20160311786
2016-10-27

HIV protease inhibitors

#2490
20160311782
2016-10-27

N-arylmethyl sulfonamide negative modulators of NR2A

#2491
20160311774
2016-10-27

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

#2492
20160310471
2016-10-27

GLP-1 receptor stabilizers and modulators

#2493
20160310447
2016-10-27

Compositions and methods for treating respiratory injury or disease

#2494
20160304833
2016-10-20

Methods of enhancing cell survival of stem cells

#2495
20160304533
2016-10-20

Compounds, compositions and methods for inhibiting CNKSR1

#2496
20160304505
2016-10-20

2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease

#2497
20160304500
2016-10-20

Methods of promoting wound healing using CRM1 inhibitors

#2498
20160304466
2016-10-20

NOVEL COMPOUNDS AS JNK KINASE INHIBITORS

#2499
20160304450
2016-10-20

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

#2500
20160303128
2016-10-20

Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors

#2501
20160302414
2016-10-20

INSECTICIDAL COMPOUNDS

#2502
20160297810
2016-10-13

Viral replication inhibitors

#2503
20160297809
2016-10-13

Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug

#2504
20160297796
2016-10-13

Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

#2505
20160297789
2016-10-13

Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases

#2506
20160297780
2016-10-13

Preparation of cobicistat intermediates

#2507
20160297775
2016-10-13

Quinazoline derivatives as TAM family kinase inhibitors

#2508
20160297762
2016-10-13

S1P3 antagonists

#2509
20160297756
2016-10-13

Pyrrolidinones as herbicides

#2510
20160289224
2016-10-06

Antifungal treatment

#2511
20160289216
2016-10-06

Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1

#2512
20160289211
2016-10-06

CERTAIN HETEROCYCLES, COMPOSITIONS THEREOF, AND METHODS FOR THEIR USE

#2513
20160289210
2016-10-06

Substituted pyridine derivatives useful as GSK-3 inhibitors

#2514
20160289196
2016-10-06

Pyrazole derivatives as TNIK, IKKϵ and TBK1 inhibitor and pharmaceutical composition comprising same

#2515
20160289171
2016-10-06

IDO inhibitors

#2516
20160280922
2016-09-29

Disperse dyes, their preparation and their use

#2517
20160280703
2016-09-29

Heteroaryloxycarbocyclyl Compounds as PDE 10 Inhibitors

#2518
20160280702
2016-09-29

Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

#2519
20160280695
2016-09-29

Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use

#2520
20160280672
2016-09-29

Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound

#2521
20160280656
2016-09-29

6-aminoisoquinoline compounds

#2522
20160280649
2016-09-29

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

#2523
20160272654
2016-09-22

SPIROCYCLIC DIHYDRO-THIAZINE AND DIHYDRO-OXAZINE BACE INHIBITORS, AND COMPOSITIONS AND USES THEREOF

#2524
20160272653
2016-09-22

Pro-drugs of NSAIAs with very high skin and membranes penetration rates and their new medicinal uses

#2525
20160272639
2016-09-22

Compounds and methods for the enhanced degradation of targeted proteins

#2526
20160272628
2016-09-22

3-indol substituted derivatives, pharmaceutical compositions and methods for use

#2527
20160272601
2016-09-22

Antibacterial thiazolecarboxylic acids

#2528
20160272596
2016-09-22

Tetrahydro-benzodiazepinones

#2529
20160272589
2016-09-22

DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE

#2530
20160270399
2016-09-22

Tetrazolinone compound and use thereof

#2531
20160264596
2016-09-15

Substituted benzamides

#2532
20160264567
2016-09-15

Substituted sulfonamide compounds

#2533
20160264566
2016-09-15

Anti-alphavbeta1 integrin inhibitors and methods of use

#2534
20160264565
2016-09-15

CRYSTALLINE DASATINIB PROCESS

#2535
20160264555
2016-09-15

Quinazoline derivative

#2536
20160264538
2016-09-15

C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their use

#2537
20160264537
2016-09-15

CYCLIC PROTEIN TYROSINE KINASE INHIBITORS

#2538
20160264535
2016-09-15

BENZOFURAZAN ANTI-AMYLOID COMPOUNDS AND METHODS

#2539
20160264518
2016-09-15

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#2540
20160263122
2016-09-15

Compounds

#2541
20160263084
2016-09-15

Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

#2542
20160257658
2016-09-08

2-acylaminothiazoles for the treatment of cancer

#2543
20160257655
2016-09-08

Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)

#2544
20160257653
2016-09-08

Benzazepine dicarboxamide compounds

#2545
20160257641
2016-09-08

Alkylene derivatives

#2546
20160249617
2016-09-01

Tetrazolinone compound and use thereof

#2547
20160244464
2016-08-25

SUBSTITUTED BENZENE COMPOUNDS

#2548
20160244446
2016-08-25

Heteroaryl Syk inhibitors

#2549
20160244415
2016-08-25

Substituted uracils as chymase inhibitors

#2550
20160243121
2016-08-25

Quinazoline derivatives, compositions, and uses related thereto

#2551
20160243100
2016-08-25

4-methylsulfonyl-substituted piperidine urea compounds

#2552
20160237077
2016-08-18

Process for the industrial synthesis of lurasidone

#2553
20160237076
2016-08-18

Deoxycytidine kinase inhibitors

#2554
20160237070
2016-08-18

1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

#2555
20160237058
2016-08-18

PHENOXY THIOPHENE SULFONAMIDES AND OTHER COMPOUNDS FOR USE AS INHIBITORS OF BACTERIAL GLUCURONIDASE

#2556
20160237036
2016-08-18

AZACYCLIC COMPOUNDS

#2557
20160235729
2016-08-18

2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders

#2558
20160235706
2016-08-18

Indanyloxydihydrobenzofuranylacetic acids

#2559
20160235065
2016-08-18

Tetrazolinone compound and use thereof

#2560
20160229848
2016-08-11

Benzazepine ketone compounds as glycogen phosphorylase inhibitor, preparation method therefor, and medical uses

#2561
20160229830
2016-08-11

Glucosylceramide synthase inhibitors for the treatment of diseases

#2562
20160229816
2016-08-11

Cyanotriazole compounds

#2563
20160229814
2016-08-11

Heterocyclic compound

#2564
20160229796
2016-08-11

Metformin salts to treat Type2 diabetes

#2565
20160228450
2016-08-11

GLP-1 receptor modulators

#2566
20160228407
2016-08-11

1,2- bis-sulfonamide derivatives as chemokine receptor modulators

#2567
20160222032
2016-08-04

C5-spiro iminothiazine dioxides as BACE inhibitors, compositions, and their use

#2568
20160222030
2016-08-04

Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders

#2569
20160222011
2016-08-04

COMT inhibiting methods and compositions

#2570
20160222004
2016-08-04

Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists

#2571
20160222002
2016-08-04

TRPV1 antagonists including dihydroxy substituent and uses thereof

#2572
20160222001
2016-08-04

COMT inhibiting methods and compositions

#2573
20160221998
2016-08-04

Heterocyclic amide compound and herbicide

#2574
20160221974
2016-08-04

SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN AND DIABETES

#2575
20160221945
2016-08-04

SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS

#2576
20160220564
2016-08-04

Substituted quinoxalines as FGFR kinase inhibitors

#2577
20160219879
2016-08-04

FUNGICIDAL COMPOSITIONS

#2578
20160214993
2016-07-28

GLP-1 receptor modulators

#2579
20160214985
2016-07-28

PRMT5 inhibitors and uses thereof

#2580
20160214972
2016-07-28

Compounds and methods for the targeted degradation of androgen receptor

#2581
20160214971
2016-07-28

Biaryl acyl-sulfonamide compounds as sodium channel inhibitors

#2582
20160213652
2016-07-28

Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use

#2583
20160207940
2016-07-21

HETEROCYCLIC COMPOUNDS AND USES THEREOF

#2584
20160207913
2016-07-21

Prodrugs of amino quinazoline kinase inhibitor

#2585
20160207912
2016-07-21

Heteroaryl amides as inhibitors of protein aggregation

#2586
20160207905
2016-07-21

Substituted pyrimidine compounds, compositions and medicinal applications thereof

#2587
20160205935
2016-07-21

Tetrazolinone compound and use of same

#2588
20160205933
2016-07-21

N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide for control of agricultural/horticultural pests

#2589
20160200718
2016-07-14

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

#2590
20160200716
2016-07-14

COBICISTAT DICHLOHYDRATE SALT

#2591
20160200714
2016-07-14

3-substituted cyclopentylamine derivatives

#2592
20160200695
2016-07-14

Methods and compositions for selective and targeted cancer therapy

#2593
20160200686
2016-07-14

Benzimidazolyl-methyl urea derivatives as ALX receptor agonists

#2594
20160200674
2016-07-14

IDO inhibitors

#2595
20160194314
2016-07-07

Pi-kinase inhibitors with anti-infective activity

#2596
20160194313
2016-07-07

Indole amide compound as inhibitor of necrosis

#2597
20160194299
2016-07-07

COMPOUNDS FOR TREATMENT OF DRUG RESISTANT AND PERSISTENT TUBERCULOSIS

#2598
20160193347
2016-07-07

Multi-targeted Ubenimex prodrug derivative and preparation method and use thereof

#2599
20160193217
2016-07-07

Therapeutic agent for ophthalmic disease

#2600
20160185726
2016-06-30

Anthelmintic compounds and compositions and method of using thereof

#2601
20160184308
2016-06-30

Aminopyrimidine derivatives for use as modulators of kinase activity

#2602
20160184265
2016-06-30

Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders

#2603
20160177363
2016-06-23

Processes for preparing tubulysins

#2604
20160176861
2016-06-23

Hydroxy containing FXR (NR1H4) modulating compounds

#2605
20160176860
2016-06-23

Inhibitors of LC3/ATG3 interaction and their use in the treatment of cancer

#2606
20160176857
2016-06-23

3,5-diaminopyrazole kinase inhibitors

#2607
20160176831
2016-06-23

11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists

#2608
20160175303
2016-06-23

Synthesis of new benzothiazole derivatives as potential anti-tubercular agents

#2609
20160168165
2016-06-16

Myc modulators and uses thereof

#2610
20160168146
2016-06-16

Compounds and methods for kinase modulation, and indications therefor

#2611
20160168144
2016-06-16

COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF EPSTEIN-BARR NUCLEAR ANTIGEN 1

#2612
20160168143
2016-06-16

Salts of Dasatinib in crystalline form

#2613
20160168142
2016-06-16

Salts of dasatinib in amorphous form

#2614
20160168141
2016-06-16

Aryl sultam derivatives as RORc modulators

#2615
20160168119
2016-06-16

AUTOTAXIN INHIBITORS

#2616
20160168090
2016-06-16

Indole derivatives and their use in neurodegenerative diseases

#2617
20160159784
2016-06-09

N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof

#2618
20160158241
2016-06-09

N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer

#2619
20160158230
2016-06-09

2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer

#2620
20160158228
2016-06-09

SUSTAINED-RELEASE FORMULATION FOR INJECTION

#2621
20160157491
2016-06-09

Pesticide compounds

#2622
20160152621
2016-06-02

Aryl lactam kinase inhibitors

#2623
20160152608
2016-06-02

Benzimidazole derivatives as selective proteine kinase inhibitors

#2624
20160152569
2016-06-02

Pyridyl inhibitors of hedgehog signalling

#2625
20160150782
2016-06-02

USE OF SELECTED PYRIDONE CARBOXAMIDES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS

#2626
20160145247
2016-05-26

Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof

#2627
20160145223
2016-05-26

Bicyclyl-Substituted Isothiazoline Compounds

#2628
20160143915
2016-05-26

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

#2629
20160143870
2016-05-26

IDO inhibitors

#2630
20160137692
2016-05-19

Targeted nitroxide agents

#2631
20160137667
2016-05-19

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#2632
20160137636
2016-05-19

Bicyclic sulfonamide compounds as sodium channel inhibitors

#2633
20160137606
2016-05-19

NOVEL PYRIDINE DERIVATIVES

#2634
20160136164
2016-05-19

Methods and compositions for the treatment of cancer and related hyperproliferative disorders

#2635
20160135464
2016-05-19

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

#2636
20160130267
2016-05-12

2-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors

#2637
20160130266
2016-05-12

α-oxoacyl amino-caprolactam

#2638
20160130262
2016-05-12

N-substituted azetidine derivatives

#2639
20160130239
2016-05-12

Sodium channel modulators for the treatment of pain and diabetes

#2640
20160129032
2016-05-12

Substituted quinazolines as receptor-type kinase inhibitors

#2641
20160128993
2016-05-12

1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer

#2642
20160126022
2016-05-05

Organic dyes comprising a hydrazone moiety and their use in dye-sensitized solar cells

#2643
20160120851
2016-05-05

Benzothiazole derivatives and a use thereof for the treatment of cancer

#2644
20160115160
2016-04-28

2,3-butanediamide epoxide compound and preparation method and use thereof

#2645
20160115133
2016-04-28

Compounds, compositions and methods

#2646
20160115119
2016-04-28

α-Substituted glycinamide derivative

#2647
20160108052
2016-04-21

SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY

#2648
20160108028
2016-04-21

1,2,5-substituted benzimidazoles as flap modulators

#2649
20160108025
2016-04-21

POLYCYCLIC HERG ACTIVATORS

#2650
20160107996
2016-04-21

Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof

#2651
20160106742
2016-04-21

Pyruvate kinase activators for use in therapy

#2652
20160102087
2016-04-14

Compounds and methods for the treatment of isocitrate dehydrogenase related diseases

#2653
20160102086
2016-04-14

NOVEL FORMULATION OF MELOXICAM

#2654
20160102085
2016-04-14

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

#2655
20160102084
2016-04-14

Compositions and methods for inhibition of the JAK pathway

#2656
20160102054
2016-04-14

Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)

#2657
20160101102
2016-04-14

Piperazine thiazole derivatives useful in the treatment of tauopathies such as Alzheimer's disease

#2658
20160096831
2016-04-07

Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto

#2659
20160096830
2016-04-07

Inhibitors of lysine gingipain

#2660
20160096824
2016-04-07

Heterocyclic compounds useful for kinase inhibition

#2661
20160096811
2016-04-07

Benzoisothiazole compounds and methods of treating schizophrenia

#2662
20160096804
2016-04-07

Histone deacetylase inhibitors

#2663
20160095858
2016-04-07

Modulators of cystic fibrosis transmembrane conductance regulator

#2664
20160090375
2016-03-31

Substituted phenylazole derivative

#2665
20160090364
2016-03-31

PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS

#2666
20160083370
2016-03-24

Substituted heteroaryl compounds and methods of use thereof

#2667
20160083354
2016-03-24

Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same

#2668
20160083342
2016-03-24

Sulfur derivatives as chemokine receptor modulators

#2669
20160081982
2016-03-24

Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

#2670
20160075657
2016-03-17

Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereof

#2671
20160074408
2016-03-17

Compositions useful in treating brain-related diseases or disorders and methods using same

#2672
20160068522
2016-03-10

Inhibitors of leukotriene A4 hydrolase

#2673
20160068487
2016-03-10

Compounds as diacylglycerol acyltransferase inhibitors

#2674
20160067224
2016-03-10

Therapeutic compounds

#2675
20160060256
2016-03-03

Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors

#2676
20160060255
2016-03-03

Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors

#2677
20160060254
2016-03-03

Thiazole-based inhibitors of scavenger receptor BI

#2678
20160060233
2016-03-03

Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto

#2679
20160060224
2016-03-03

N-myristoyl transferase inhibitors

#2680
20160060222
2016-03-03

AMINO-QUINOLINES AS KINASE INHIBITORS

#2681
20160052966
2016-02-25

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

#2682
20160052935
2016-02-25

COMPOUNDS FOR USE IN SCREENING METHODS FOR SPINAL MUSCULAR ATROPHY

#2683
20160052926
2016-02-25

NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND USAGE THEREOF

#2684
20160052895
2016-02-25

Small molecule mediated transcriptional induction of E-cadherin

#2685
20160052890
2016-02-25

Compounds useful as antibiotic tolerance inhibitors

#2686
20160052884
2016-02-25

Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders

#2687
20160050925
2016-02-25

Fungicidal amides

#2688
20160046651
2016-02-18

TREATMENT OF MALARIA USING INHIBITORS OF THE ISPD ENZYME IN THE NON-MEVALONATE PATHWAY

#2689
20160046626
2016-02-18

Bicyclic sulfonamide compounds as sodium channel inhibitors

#2690
20160046625
2016-02-18

BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE

#2691
20160046618
2016-02-18

Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use

#2692
20160046617
2016-02-18

Sodium channel modulators for the treatment of pain

#2693
20160046616
2016-02-18

NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY

#2694
20160046612
2016-02-18

Heterocyclic derivative and pharmaceutical drug

#2695
20160046600
2016-02-18

1,2,5-Substituted benzimidazoles as flap modulators

#2696
20160046579
2016-02-18

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#2697
20160046574
2016-02-18

Serotonin receptor modulators

#2698
20160039838
2016-02-11

Aminoquinazoline derivatives and their salts and methods of use thereof

#2699
20160039806
2016-02-11

Method of preparing glucosylceramide synthase inhibitors

#2700
20160039771
2016-02-11

Dihydroxy aromatic heterocyclic compound